Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A van der Reijden

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Leukemia|April 17, 2008
C/EBPalpha, do not forget your TIP60C W E So, B A van der Reijden
Blood|March 15, 1996
Novel CBFB-MYH11 fusion transcripts or reverse transcription-polymerase chain reaction artifacts?B A van der Reijden, A Hagemeijer, M H Breuning
Leukemia|June 24, 2000
Deletion of the multidrug resistance-associated protein (MRP1) gene in acute myeloid leukemia with inversion of chromosome 16 has no prognostic impactK Döhner, R F Schlenk, B A van der Reijden, et al.
Leukemia|August 24, 2006
Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targetsJ A F Marteijn, J H Jansen, B A van der Reijden
Leukemia|September 24, 2010
Gfi1 and Gfi1b: key regulators of hematopoiesisL T van der Meer, J H Jansen, B A van der Reijden
Leukemia|February 3, 1998
Acute leukemias with structurally altered core binding factor subunits (t(8;21), inv(16), t(12;21)), 27-28 June 1997, Rotterdam, The NetherlandsB A van der Reijden, C D Bloomfield, I P Touw, et al.
Leukemia|February 1, 1996
Acute myelogenous leukemia: a disorder of gene splicing?B A van der Reijden, G J van Ommen, A Hagemeijer, et al.
Protein Science : a Publication of the Protein Society|July 28, 1999
TRIADs: a new class of proteins with a novel cysteine-rich signatureB A van der Reijden, C A Erpelinck-Verschueren, B Löwenberg, et al.
Blood Cancer Journal|August 2, 2014
High DNA-methyltransferase 3B expression predicts poor outcome in acute myeloid leukemia, especially among patients with co-occurring NPM1 and FLT3 mutationsD Monteferrario, S M Noordermeer, S Bergevoet, et al.
Bone Marrow Transplantation|June 26, 2007
Therapy-related, donor-derived AML responding to a second allogeneic BMTJ F M Jacobs, P P Brons, A Simons, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Leukemia|April 17, 2008
C/EBPalpha, do not forget your TIP60C W E So, B A van der Reijden
Blood|March 15, 1996
Novel CBFB-MYH11 fusion transcripts or reverse transcription-polymerase chain reaction artifacts?B A van der Reijden, A Hagemeijer, M H Breuning
Leukemia|June 24, 2000
Deletion of the multidrug resistance-associated protein (MRP1) gene in acute myeloid leukemia with inversion of chromosome 16 has no prognostic impactK Döhner, R F Schlenk, B A van der Reijden, et al.
Leukemia|August 24, 2006
Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targetsJ A F Marteijn, J H Jansen, B A van der Reijden
Leukemia|September 24, 2010
Gfi1 and Gfi1b: key regulators of hematopoiesisL T van der Meer, J H Jansen, B A van der Reijden
Leukemia|February 3, 1998
Acute leukemias with structurally altered core binding factor subunits (t(8;21), inv(16), t(12;21)), 27-28 June 1997, Rotterdam, The NetherlandsB A van der Reijden, C D Bloomfield, I P Touw, et al.
Leukemia|February 1, 1996
Acute myelogenous leukemia: a disorder of gene splicing?B A van der Reijden, G J van Ommen, A Hagemeijer, et al.
Protein Science : a Publication of the Protein Society|July 28, 1999
TRIADs: a new class of proteins with a novel cysteine-rich signatureB A van der Reijden, C A Erpelinck-Verschueren, B Löwenberg, et al.
Blood Cancer Journal|August 2, 2014
High DNA-methyltransferase 3B expression predicts poor outcome in acute myeloid leukemia, especially among patients with co-occurring NPM1 and FLT3 mutationsD Monteferrario, S M Noordermeer, S Bergevoet, et al.
Bone Marrow Transplantation|June 26, 2007
Therapy-related, donor-derived AML responding to a second allogeneic BMTJ F M Jacobs, P P Brons, A Simons, et al.
Pageof 4